Bioprofiling and therapy of phosphaturic mesenchymal tumors (PMTs)

Bioprofiling and therapy of phosphaturic mesenchymal tumors (PMTs) - PMT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033898

Enrollment

Registered

2024-03-14

Start date

2024-01-08

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phosphaturic mesenchymal tumor (PMT)

Interventions

Group 1: Retrospective recruitment of patients with phosphaturic mesenchymal tumors who were treated at the University Medical Center Freiburg in the Department of Orthopedics and Trauma Surgery

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of phosphaturic mesenchymal tumor

Exclusion criteria

Exclusion criteria: No permission/acceptance of the patients

Design outcomes

Primary

Measure	Time frame
- Diagnostic and therapeutic biomarkers of PMTs - Adequate diagnostic and therapeutic procedures in the treatment of PMTs	—

Secondary

Measure	Time frame
- revision rate - mortality - clinical onset and symptoms - malignant transformation	—

Countries

Germany

Contacts

Public ContactJulian Maier

Klinik für Orthopädie und Unfallchirurgie, Universitätsklinikum Freiburg

julian.maier@uniklinik-freiburg.de+49 76127061301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026